Patients with T1D were more frequently prescribed ACE inhibitors and angiotensin receptor blockers (44.9% vs 32.7%), lipid-lowering drugs (36.8% vs 23.7%), calcium channel blockers (24.6% vs 15.9%) and diuretics (32.1% vs 27.0%) (online supplemental table 1). The gene discussed is ACE; the disease is type 1 diabetes mellitus.